Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2025-11-14 00:00:00 ET · period of report 2025-11-12 · accession 0001871002-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-11-14 | 2025-11-12+ | ANIP | Gassert Chad | SVP - CORP. DEV, STRATEGY | S - Sale | $89.06 | -14.7K | 158.5K | -9% | -$1.31M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-12 | S | D | 14,642 | $89.07 | 158,584 | I Held by Chali Properties LLC | — | — | (F1) The shares were sold in multiple trades at prices ranging from $89.00 to $89.50. The price reported above reflects the weighted average sales price. (F2) The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC. |
| 2 | Common | Common Stock | 2025-11-13 | S | D | 94 | $88.00 | 158,490 | I Held by Chali Properties LLC | — | — | (F2) The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC. |